Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 246

    1.

    Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro.

    Bakker WW, Henning RH, van Son WJ, van Pampus MG, Aarnoudse JG, Niezen-Koning KE, Borghuis T, Jongman RM, van Goor H, Poelstra K, Navis G, Faas MM.

    Hypertension. 2009 Jun;53(6):959-64. Epub 2009 May 4.PMID: 19414647 [PubMed - indexed for MEDLINE]Related articles

    2.

    Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.

    Forrer F, Krenning EP, Kooij PP, Bernard BF, Konijnenberg M, Bakker WH, Teunissen JJ, de Jong M, van Lom K, de Herder WW, Kwekkeboom DJ.

    Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1138-46. Epub 2009 Feb 27.PMID: 19247653 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Histochemical detection of ischemia-like alterations induced in kidney tissue in vitro--different sensitivity to oxidant stress of glomerular ENTPD1 versus E5NT.

    Vlaar AP, van Son WJ, Bakker WW.

    Nephron Physiol. 2009;111(1):p1-8. Epub 2008 Dec 16.PMID: 19169047 [PubMed - indexed for MEDLINE]Related articles

    4.

    Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.

    Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW.

    Cell Tissue Res. 2009 Jan;335(1):165-89. Epub 2008 Oct 22. Review.PMID: 18941783 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.

    Lennon R, Singh A, Welsh GI, Coward RJ, Satchell S, Ni L, Mathieson PW, Bakker WW, Saleem MA.

    J Am Soc Nephrol. 2008 Nov;19(11):2140-9. Epub 2008 Aug 27.PMID: 18753258 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation.

    Grech G, Blázquez-Domingo M, Kolbus A, Bakker WJ, Müllner EW, Beug H, von Lindern M.

    Blood. 2008 Oct 1;112(7):2750-60. Epub 2008 Jul 14.PMID: 18625885 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine.

    Bakker W, Mathias R.

    Can J Infect Dis. 2001 May;12(3):144-8.PMID: 18159331 [PubMed - in process]Related articlesFree article

    8.

    FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2.

    Bakker WJ, Harris IS, Mak TW.

    Mol Cell. 2007 Dec 28;28(6):941-53.PMID: 18158893 [PubMed - indexed for MEDLINE]Related articles

    9.

    Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries.

    Bakker W, Sipkema P, Stehouwer CD, Serne EH, Smulders YM, van Hinsbergh VW, Eringa EC.

    Diabetes. 2008 Mar;57(3):706-13. Epub 2007 Dec 17.PMID: 18086904 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Infection of human endothelium in vitro by cytomegalovirus causes enhanced expression of purinergic receptors: a potential virus escape mechanism?

    Zandberg M, van Son WJ, Harmsen MC, Bakker WW.

    Transplantation. 2007 Nov 27;84(10):1343-7.PMID: 18049120 [PubMed - indexed for MEDLINE]Related articles

    11.

    The incidence of pregnancy-induced hypertension and smoking: an alternative explanation?

    Bakker WW, Faas MM.

    Am J Obstet Gynecol. 2007 Nov;197(5):556; author reply 556-7. No abstract available. PMID: 17980213 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of high tibial osteotomy on the results of total knee arthroplasty: a matched case control study.

    van Raaij TM, Bakker W, Reijman M, Verhaar JA.

    BMC Musculoskelet Disord. 2007 Aug 3;8:74.PMID: 17683549 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue.

    Eringa EC, Bakker W, Smulders YM, Serné EH, Yudkin JS, Stehouwer CD.

    Microcirculation. 2007 Jun-Jul;14(4-5):389-402. Review.PMID: 17613810 [PubMed - indexed for MEDLINE]Related articles

    14.

    Plasma hemopexin activity in pregnancy and preeclampsia.

    Bakker WW, Donker RB, Timmer A, van Pampus MG, van Son WJ, Aarnoudse JG, van Goor H, Niezen-Koning KE, Navis G, Borghuis T, Jongman RM, Faas MM.

    Hypertens Pregnancy. 2007;26(2):227-39.PMID: 17469012 [PubMed - indexed for MEDLINE]Related articles

    15.

    Differential regulation of Foxo3a target genes in erythropoiesis.

    Bakker WJ, van Dijk TB, Parren-van Amelsvoort M, Kolbus A, Yamamoto K, Steinlein P, Verhaak RG, Mak TW, Beug H, Löwenberg B, von Lindern M.

    Mol Cell Biol. 2007 May;27(10):3839-3854.PMID: 17353275 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant]

    Prinsen AK, Jansen J, Bakker WH, Wildschut HI.

    Ned Tijdschr Geneeskd. 2006 Dec 30;150(52):2845-8. Dutch. PMID: 17319213 [PubMed - indexed for MEDLINE]Related articles

    17.

    Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.

    van Essen M, Krenning EP, Bakker WH, de Herder WW, van Aken MO, Kwekkeboom DJ.

    Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1219-27. Epub 2007 Jan 27.PMID: 17260141 [PubMed - indexed for MEDLINE]Related articles

    18.

    Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate.

    Bakker WH, Breeman WA, Kwekkeboom DJ, De Jong LC, Krenning EP.

    Q J Nucl Med Mol Imaging. 2006 Dec;50(4):265-71. Review.PMID: 17043624 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.

    van Essen M, Krenning EP, Kooij PP, Bakker WH, Feelders RA, de Herder WW, Wolbers JG, Kwekkeboom DJ.

    J Nucl Med. 2006 Oct;47(10):1599-606.PMID: 17015894 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

    Esser JP, Krenning EP, Teunissen JJ, Kooij PP, van Gameren AL, Bakker WH, Kwekkeboom DJ.

    Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1346-51. Epub 2006 Jul 18.PMID: 16847654 [PubMed - indexed for MEDLINE]Related articles

    21.

    Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.

    Valkema R, Pauwels S, Kvols LK, Barone R, Jamar F, Bakker WH, Kwekkeboom DJ, Bouterfa H, Krenning EP.

    Semin Nucl Med. 2006 Apr;36(2):147-56.PMID: 16517236 [PubMed - indexed for MEDLINE]Related articles

    22.

    Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion method.

    Engels FK, Buijs D, Loos WJ, Verweij J, Bakker WH, Krenning EP.

    Anticancer Drugs. 2006 Jan;17(1):63-7.PMID: 16317291 [PubMed - indexed for MEDLINE]Related articles

    23.

    Altered activity of plasma hemopexin in patients with minimal change disease in relapse.

    Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, Borghuis T, Kapojos JJ.

    Pediatr Nephrol. 2005 Oct;20(10):1410-5. Epub 2005 Aug 4.PMID: 16079987 [PubMed - indexed for MEDLINE]Related articles

    24.

    Protease activity of plasma hemopexin.

    Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, Niezen KE, Kapojos JJ.

    Kidney Int. 2005 Aug;68(2):603-10.PMID: 16014037 [PubMed - indexed for MEDLINE]Related articles

    25.

    Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.

    Kwekkeboom DJ, Teunissen JJ, Bakker WH, Kooij PP, de Herder WW, Feelders RA, van Eijck CH, Esser JP, Kam BL, Krenning EP.

    J Clin Oncol. 2005 Apr 20;23(12):2754-62.PMID: 15837990 [PubMed - indexed for MEDLINE]Related articles

    26.

    Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.

    Teunissen JJ, Kwekkeboom DJ, Kooij PP, Bakker WH, Krenning EP.

    J Nucl Med. 2005 Jan;46 Suppl 1:107S-14S.PMID: 15653659 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

    Valkema R, Pauwels SA, Kvols LK, Kwekkeboom DJ, Jamar F, de Jong M, Barone R, Walrand S, Kooij PP, Bakker WH, Lasher J, Krenning EP.

    J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S.PMID: 15653656 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Enhanced ecto-apyrase activity of stimulated endothelial or mesangial cells is downregulated by glucocorticoids in vitro.

    Kapojos JJ, van den Berg A, Borghuis T, Banas B, Huitema S, Poelstra K, Bakker WW.

    Eur J Pharmacol. 2004 Oct 6;501(1-3):191-8.PMID: 15464078 [PubMed - indexed for MEDLINE]Related articles

    29.

    Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells.

    Kapojos JJ, Poelstra K, Borghuis T, Banas B, Bakker WW.

    Nephron Physiol. 2004;96(1):P1-10.PMID: 14752238 [PubMed - indexed for MEDLINE]Related articles

    30.

    FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1.

    Bakker WJ, Blázquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H, Coffer PJ, Löwenberg B, von Lindern M, van Dijk TB.

    J Cell Biol. 2004 Jan 19;164(2):175-84.PMID: 14734530 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Site-specific intracoronary delivery of octreotide in humans: a pharmacokinetic study to determine dose-efficacy in restenosis prevention.

    Camenzind E, Bakker WH, Reijs A, Righetti A, van Geijlswijk IM, Boersma E, Foley D, Krenning EP, Roelandt JR, Serruys PW.

    J Cardiovasc Pharmacol. 2004 Jan;43(1):133-9.PMID: 14668579 [PubMed - indexed for MEDLINE]Related articles

    32.

    Induction of glomerular alkaline phosphatase after challenge with lipopolysaccharide.

    Kapojos JJ, Poelstra K, Borghuis T, Van Den Berg A, Baelde HJ, Klok PA, Bakker WW.

    Int J Exp Pathol. 2003 Jun;84(3):135-44.PMID: 12974943 [PubMed - indexed for MEDLINE]Related articles

    33.

    Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling.

    Kolbus A, Blázquez-Domingo M, Carotta S, Bakker W, Luedemann S, von Lindern M, Steinlein P, Beug H.

    Blood. 2003 Nov 1;102(9):3136-46. Epub 2003 Jul 17.PMID: 12869505 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based catheter system.

    Smits PC, van Langenhove G, Schaar M, Reijs A, Bakker WH, van der Giessen WJ, Verdouw PD, Krenning EP, Serruys PW.

    Cardiovasc Drugs Ther. 2002 Dec;16(6):527-33.PMID: 12766387 [PubMed - indexed for MEDLINE]Related articles

    35.

    Production of hemopexin by TNF-alpha stimulated human mesangial cells.

    Kapojos JJ, van den Berg A, van Goor H, te Loo MW, Poelstra K, Borghuis T, Bakker WW.

    Kidney Int. 2003 May;63(5):1681-6.PMID: 12675843 [PubMed - indexed for MEDLINE]Related articles

    36.

    Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.

    Kwekkeboom DJ, Bakker WH, Kam BL, Teunissen JJ, Kooij PP, de Herder WW, Feelders RA, van Eijck CH, de Jong M, Srinivasan A, Erion JL, Krenning EP.

    Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):417-22. Epub 2003 Jan 9.PMID: 12634971 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Clinical relevance of immunohistochemical staining for ecto-AMPase and ecto-ATPase in chronic allograft nephropathy (CAN).

    Mui KW, van Son WJ, Tiebosch AT, van Goor H, Bakker WW.

    Nephrol Dial Transplant. 2003 Jan;18(1):158-63.PMID: 12480975 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    De-novo expression of vascular ecto-5'-nucleotidase and down-regulation of glomerular ecto-ATPase in experimental chronic renal transplant failure.

    Smit-van Oosten A, Bakker WW, van Goor H.

    Transpl Int. 2002 Dec;15(12):602-9. Epub 2002 Oct 26.PMID: 12478406 [PubMed - indexed for MEDLINE]Related articles

    39.

    Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU.

    Nanda D, de Jong M, Vogels R, Havenga M, Driesse M, Bakker W, Bijster M, Avezaat C, Cox P, Morin K, Naimi E, Knaus E, Wiebe L, Smitt PS.

    Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):939-47.PMID: 12212546 [PubMed - indexed for MEDLINE]Related articles

    40.

    Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

    De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP.

    Semin Nucl Med. 2002 Apr;32(2):133-40. Review.PMID: 11965608 [PubMed - indexed for MEDLINE]Related articles

    41.

    Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.

    Valkema R, De Jong M, Bakker WH, Breeman WA, Kooij PP, Lugtenburg PJ, De Jong FH, Christiansen A, Kam BL, De Herder WW, Stridsberg M, Lindemans J, Ensing G, Krenning EP.

    Semin Nucl Med. 2002 Apr;32(2):110-22.PMID: 11965606 [PubMed - indexed for MEDLINE]Related articles

    42.

    Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.

    de Jong M, Breeman WA, Bernard BF, Bakker WH, Visser TJ, Kooij PP, van Gameren A, Krenning EP.

    J Nucl Med. 2001 Dec;42(12):1841-6.PMID: 11752083 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Nitric oxide inhibition enhances platelet aggregation in experimental anti-Thy-1 nephritis.

    van Goor H, Albrecht EW, Heeringa P, Klok PA, van der Horst ML, de Jager-Krikken A, Bakker WW, Moshage H.

    Nitric Oxide. 2001 Dec;5(6):525-33.PMID: 11730359 [PubMed - indexed for MEDLINE]Related articles

    44.

    Design and synthesis of a maximally diverse and druglike screening library using REM resin methodology.

    Barn D, Caulfield W, Cowley P, Dickins R, Bakker WI, McGuire R, Morphy JR, Rankovic Z, Thorn M.

    J Comb Chem. 2001 Nov-Dec;3(6):534-41.PMID: 11703148 [PubMed - indexed for MEDLINE]Related articles

    45.

    Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.

    Breeman WA, de Jong M, Kwekkeboom DJ, Valkema R, Bakker WH, Kooij PP, Visser TJ, Krenning EP.

    Eur J Nucl Med. 2001 Sep;28(9):1421-9. Review.PMID: 11585303 [PubMed - indexed for MEDLINE]Related articles

    46.

    [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

    Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP.

    Eur J Nucl Med. 2001 Sep;28(9):1319-25.PMID: 11585290 [PubMed - indexed for MEDLINE]Related articles

    47.

    [177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.

    de Jong M, Breeman WA, Bernard BF, Bakker WH, Schaar M, van Gameren A, Bugaj JE, Erion J, Schmidt M, Srinivasan A, Krenning EP.

    Int J Cancer. 2001 Jun 1;92(5):628-33.PMID: 11340564 [PubMed - indexed for MEDLINE]Related articles

    48.

    Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells.

    Kas-Deelen AM, Bakker WW, Olinga P, Visser J, de Maar EF, van Son WJ, The TH, Harmsen MC.

    FEBS Lett. 2001 Feb 23;491(1-2):21-5.PMID: 11226411 [PubMed - indexed for MEDLINE]Related articles

    49.

    Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.

    Bernard BF, Krenning E, Breeman WA, Visser TJ, Bakker WH, Srinivasan A, de Jong M.

    Nucl Med Commun. 2000 Nov;21(11):1079-85.PMID: 11192715 [PubMed - indexed for MEDLINE]Related articles

    50.

    Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.

    Kwekkeboom DJ, Bakker WH, Kooij PP, Erion J, Srinivasan A, de Jong M, Reubi JC, Krenning EP.

    Eur J Nucl Med. 2000 Sep;27(9):1312-7.PMID: 11007512 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...